- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05870137
Assessing Mixed Reality for Emergency Medical Care Delivery in a Simulated Environment
A Pilot Randomised Cross-over Trial of HoloLens2™️ for the Delivery of Distributed Medical Care During COVID-19 in a Simulated Environment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, W2 1NY
- Department of Surgery and Cancer Imperial College London
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All participants must provide consent to participate in the study
- Participants must receive a standardised HL2 headset and operational tutorial
- Participants must complete a qualitative questionnaire to determine their clinical experience and exposure to the technology prior to commencement of the study
- Participants must pass a competency test to ensure standardised basic technical competency and mitigate device related first-use learning effects
Exclusion Criteria:
- Not currently working in emergency medicine/trauma setting
- No prior course completion (Advance trauma and Basic Life support)
Prior to the commencement of the study, all eligible participants were required to provide their consent to participate. Participants were then provided with a standardized HL2 headset and operational tutorial, and completed a qualitative questionnaire to assess their clinical experience and exposure to the technology. The tutorial, which was guided by the research team, included a practical induction providing fundamentals of use, how to make and receive calls, and how to use the clinical data assets provided. Participants were also required to pass a competency test to ensure standardized basic technical competency and mitigate device-related first-use learning effects.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard care
Standard care was delivered by the participants with access to didactic instruction and telephonic support.
Participants had access to all resources through standard ward base computer systems.
Access to senior support through telephone call using a bleep/on call system standard to practice within the institution.
|
The standard care for the intervention involved participants performing the invasive technical procedure to treat a tension pneumothorax using their standard clinical skills and knowledge, without the aid of the HoloLens2 device.
The participants in the standard care group did not receive any additional support or guidance beyond what is typically available in a clinical setting.
The goal of the study was to compare the effectiveness of the standard care approach with the use of Mixed Reality-supported care using the HoloLens2 device.
|
|
Experimental: Mixed reality - HoloLens2TM Supported care
HL2 supported care made all of these resources available through interaction with the HL2 device.
Participants had access to all resources through the Mixed reality device (HoloLens2).
Access to senior support through using the HL2 device.
|
Participants assigned to Mixed Reality-supported care used the HoloLens2 device, which provided support using technology that was permitted by the device.
This support included remote assistance and holographic versions of patient-specific investigation results, such as radiological findings, biochemistry, and guidelines for completing the procedure (insertion of chest drain).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Error Rate
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The primary outcome measure for this study was the error rate, which was assessed using the ICECAP tool (Imperial College Error CAPture).
This is a validated, multidimensional tool that assesses errors across several domains, including equipment, communication, technical aspects, patient-related factors, procedure-independent pressures, and a category for capturing any other errors that are not specified.
Using the ICECAP tool provides a comprehensive assessment of errors and allows for identifying areas of improvement across multiple domains.
Each time an error is observed the participant is attributed 1 score per error within the respective category.
The total number of errors is accumulated throughout completion of the scenario.
The error is reported as a sum of the total errors observed, as well as per category to determine if there is any specific areas that error rate is impacted.
|
Through study completion, an average of 8 minutes per scenario
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scenario completion success
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The secondary outcome measure was the successful completion of the clinical scenario.
This was determined by the simulation team assessing whether the participant was able to successfully insert the chest drain and complete a life-saving intervention in the simulated environment.
If the participant was unable to appropriately insert the chest drain, this was considered an adverse outcome for the simulated patient, and thus the scenario was deemed unsuccessful.
|
Through study completion, an average of 8 minutes per scenario
|
|
Scenario completion duration
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The secondary outcome measure was the time taken to complete the clinical scenario.
This was recorded by the simulation team from the initiation of the scenario to the successful completion, which involved both the insertion of the chest drain and the completion of the intervention.
If the participant expressed their desire to discontinue the intervention, this was also recorded as the endpoint of the scenario.
|
Through study completion, an average of 8 minutes per scenario
|
|
Team performance
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The OTAS tool (Observational Teamwork Assessment for Surgery) is a validated scale that is commonly used to assess team performance in surgery. It is a structured observation tool that allows for the assessment of teamwork in the operating room setting, and it has been shown to have good inter-rater reliability and construct validity. The tool can also be used to compare the performance of individual team members and to determine how the use of technology influences cognitive load and individual perspective performance. For example, studies have used the OTAS tool to evaluate the impact of laparoscopic surgery on team performance and to determine how the use of surgical robots affects teamwork and communication in the operating room. |
Through study completion, an average of 8 minutes per scenario
|
|
Team performance
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The T-SAW-C Tool (Teamwork Skills Assessment for Ward Care) was used by observers to assess teamwork during the simulated scenarios.
This tool measures various aspects of teamwork, such as communication, coordination, and cooperation, and has been validated for use in healthcare settings.
By including this information, it clarifies the measurement tool being used to assess the specific outcome measure of interest.
|
Through study completion, an average of 8 minutes per scenario
|
|
Team workload
Time Frame: Through study completion, an average of 8 minutes per scenario
|
The NASA Task Load Index (TLX) is a subjective multidimensional assessment tool that rates perceived workload in order to assess a task, system, or team's effectiveness or other aspects of performance.
It uses a Likert scale with six domains, each attributed a weight ranging from 0 to 5. The scale ratings are scored based on where the user marked the scale.
Tick marks range from 0 to 100 by 5 point increments, and scores are given for the tick at or immediately above the mark.
Higher scores indicate a greater perceived workload.
|
Through study completion, an average of 8 minutes per scenario
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: James Kinross, PhD FRCS, Senior Lecturer in Surgery and Consultant Surgeon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21SM6714
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergency Medicine
-
Samsung Medical CenterRecruitingEmergency Medicine | Medical Informatics | Pediatric Emergency MedicineKorea, Republic of
-
Universiti Sains MalaysiaEnrolling by invitationEmergency Medicine | Regional AnaesthesiaMalaysia
-
RWTH Aachen UniversityCompletedTelemedicine | Disaster Medicine | Emergency MedicineGermany
-
Washington University School of MedicineEpharmix, Inc.CompletedEmergency Medicine | Mobile Health | General MedicineUnited States
-
Mario Negri Institute for Pharmacological ResearchCentre Hospitalier Universitaire Vaudois; Fondazione Bruno Kessler; Astir s.r.l. and other collaboratorsRecruitingEmergency MedicineItaly
-
Guangdong Provincial People's HospitalRecruiting
-
Massachusetts General HospitalTerminatedEmergency MedicineUnited States
-
Ataturk UniversityCompletedEmergency MedicineTurkey
-
Mario Negri Institute for Pharmacological ResearchFondazione Bruno Kessler; Astir s.r.l.; Orobix Life S.r.l.Recruiting
-
University of AarhusAarhus University Hospital; Herning Hospital; Horsens Hospital; Randers Regional... and other collaboratorsCompleted
Clinical Trials on Standard care
-
University of LahoreRecruitingDiabetic Foot UlcerPakistan
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
The General Hospital of Western Theater CommandRecruitingMucositis | Hematopoietic Stem Cell Transplantation | Radiation-Induced Mucositis | Chemotherapy-Induced MucositisChina
-
brett rasmussenCompleted
-
Queen Mary University of LondonCompleted
-
University of Missouri-ColumbiaCompletedLow Back Pain | Pelvic Pain | Adhesions | Scar TissueUnited States